go back

Prostate Cancer Antibody Response Score

Nebraska rates for HCPCS 0021U

Assesses the likelihood of prostate cancer by measuring the immune system's antibody response to eight tumor-associated proteins, including ARF6, NKX3-1, BMI1, CEP164, Ropporin, desmocollin, AURKAIP-1 and CSNK2A2. The eight results are combined into a single risk score, and no genetic material is examined.

Facilitymedian $1,514 · 10th–90th $457$3,8020%10%10th90th$1,514Professionalmedian $575 · 10th–90th $457$1,1480%20%10th90th$575$500.0$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$758.58
Median
$1,995.26
Typical High
$3,801.89
Aetna
Setting
Professional
Modifier
Global
Typical Low
$501.19
Median
$575.44
Typical High
$912.01
BCBS
Setting
Facility
Modifier
Global
Typical Low
$891.25
Median
$1,148.15
Typical High
$2,238.72
BCBS
Setting
Professional
Modifier
Global
Typical Low
$812.83
Median
$1,174.90
Typical High
$1,258.93
Cigna
Setting
Professional
Modifier
Global
Typical Low
$870.96
Median
$1,445.44
Typical High
$1,819.70
Medica
Setting
Facility
Modifier
Global
Typical Low
$275.42
Median
$501.19
Typical High
$3,630.78
Medica
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$831.76
United
Setting
Facility
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$912.01
United
Setting
Professional
Modifier
Global
Typical Low
$436.52
Median
$457.09
Typical High
$831.76